ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements
Aristo Bio-Tech sent a Reg 36(1)(b) web-link letter for its FY 2025-26 Annual Report to shareholders without email IDs. No financial or business event is disclosed.
Aristo Bio-Tech and Lifescience Limited has issued a notice for its 21st Annual General Meeting to be held on September 30, 2026.
Aristo Bio-Tech declared a final dividend of Rs. 0.60 per share and approved re-appointments for directors and the cost auditor.
Aristo Bio-Tech and Lifescience Ltd reported revenue from operations of ₹107.3 Cr (+3.3% YoY) and net profit of ₹3 Cr for H2 FY26.